Back to 
XTX Topco Ltd
XTX Topco Ltd
BLRX2 quarters
Position history for XTX Topco Ltd's holdings in BIOLINE RX LIMITED
No. XTX Topco exited its BLRX (Bioline RX) position in Q2 2026. Its Q1 2026 13F listed 10,941 shares worth $25,274. XTX Topco first reported BLRX in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$25,274
Total Shares Change
-10,941
Quarter-by-Quarter History
Other major holders of BLRX: CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SIMPLEX TRADING, LLC